Literature DB >> 19715936

Incidence and predictive factors for cytomegalovirus infection in renal transplant recipients.

A L Corona-Nakamura1, F J Monteón-Ramos, R Troyo-Sanromán, M J Arias-Merino, R Anaya-Prado.   

Abstract

BACKGROUND: Cytomegalovirus (CMV) infection is a common cause of morbidity, graft loss, and mortality among kidney recipients due to its direct and indirect influences on organs and systems, namely, immunomodulation, which favors the appearance of opportunistic infections, vasculopathy, and decreased graft and patient survival. In Mexico the dimensions of this infection are unknown in kidney transplant recipients. We evaluated the incidence and predictive factors for CMV infection among renal transplant recipients of the Mexican Institute of Social Security in Guadalajara.
METHODS: This prospective cohort analysis of patients >or=16 years of age of both genders, included transplantations from May 2006 to July 2007. Two hundred twenty-five patients were followed over 6 months to evaluate CMV infection or disease. We evaluated demographic, clinical, and paraclinical aspects, such as total lymphocyte count and quantitative CMV polymerase chain reactions (PCR).
RESULTS: The overall incidence of CMV infection was 17.8%. CMV infections were associated with lymphopenia (relative risk [RR] 14.75; confidence interval [CI] 95%, 3.46-62.77), serostatus D+/R- (RR 5.53; CI 95%, 2.18-14.05), and fever (RR 4.57; CI 95%, 1.50-13.95). Receiver-operating characteristic (ROC) curves for lymphopenia versus PCR showed a sensitivity of 27% and a specificity of 98%.
CONCLUSION: In our study, lymphopenia, serostatus D+/R-, and fever were good predictors of CMV infections among renal transplant recipients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19715936     DOI: 10.1016/j.transproceed.2009.05.008

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  5 in total

1.  Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan.

Authors:  W P Tsai; M H Chen; M H Lee; K H Yu; M W Wu; L B Liou
Journal:  Rheumatol Int       Date:  2011-09-07       Impact factor: 2.631

2.  Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Authors:  Bradley J Gardiner; Natalie E Nierenberg; Jennifer K Chow; Robin Ruthazer; David M Kent; David R Snydman
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

3.  Late Cytomegalovirus Infection in Kidney Transplant Recipients after a Six-Month Prevention Protocol.

Authors:  L Cunha; I Laranjinha; R Birne; C Jorge; T J Carvalho; A Lança; S Coelho; M Bruges; D Machado
Journal:  Int J Organ Transplant Med       Date:  2010-02-01

4.  Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy.

Authors:  Imene Handous; Bechir Achour; Manel Marzouk; Sana Rouis; Olfa Hazgui; Ines Brini; Abderrahim Khelif; Naila Hannachi; Jalel Boukadida
Journal:  Virol J       Date:  2020-03-17       Impact factor: 4.099

5.  Targeted preemptive therapy according to perceived risk of CMV infection after kidney transplantation.

Authors:  Cahue Henrique Pinto; Helio Tedesco-Silva; Claudia Rosso Felipe; Alexandra Nicolau Ferreira; Marina Cristelli; Laila Almeida Viana; Wilson Aguiar; José Medina-Pestana
Journal:  Braz J Infect Dis       Date:  2016-09-25       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.